Suzanne Catharina van Bronswijk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Suzanne Catharina van Bronswijk has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
- Lotte H. J. M. Lemmens
Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands
7 shared publications - Frenk Peeters
Maastricht University
6 shared publications Frenk P. M. L. Peeters
Department of Clinical Psychological Science, Maastricht University, Maastricht, Netherlands
5 shared publicationsMarcus J.H. Huibers
Department of Clinical Psychology, VU University Amsterdam, Van der Boechorststraat 1, 1081 BT Amsterdam, The Netherlands; Department of Psychology, University of Pennsylvania, 3720 Walnut Street, Philadelphia, PA 19104-6241, USA
5 shared publicationsArnoud Arntz
4 shared publicationsMarcus J. H. Huibers
Department of Clinical, Neuro‐ and Developmental Psychology, Amsterdam Public Health Research Institute Vrije Universiteit Amsterdam Amsterdam The Netherlands
4 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 26
Personalized treatment selection between cognitive behavioural therapy and short‑term psychodynamic supportive psychotherapy for adult outpatient depression: a proof‑of‑concept application of the Personalized Advantage Index
- 19 October 2026
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 26
Open AccessPersonalized treatment selection between cognitive behavioural therapy and short‑term psychodynamic supportive psychotherapy for adult outpatient depression: a proof‑of‑concept application of the Personalized Advantage Index
- 4 April 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 356, 115-121
Data-driven personalized medicine approaches to cognitive-behavioral therapy allocation in a large sample: A reanalysis of the ENRICHED study
- 4 April 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 356, 115-121
Data-driven personalized medicine approaches to cognitive-behavioral therapy allocation in a large sample: A reanalysis of the ENRICHED study
- Open Access
- 20 April 2022
- Published by Taylor & Francis in Psychotherapy Research
- Vol. 32 (8) , 1047-1063
Does psychological process change during psychotherapy predict long-term depression outcome after successful cognitive therapy or interpersonal psychotherapy? Secondary analysis of a randomized trial
Psychotherapies for depression are similarly effective, but the processes through which these therapies work have not been identified. We focus on psychological process changes during therapy as pr...
- 20 April 2022
- Published by Taylor & Francis in Psychotherapy Research
- Vol. 32 (8) , 1047-1063
Open AccessDoes psychological process change during psychotherapy predict long-term depression outcome after successful cognitive therapy or interpersonal psychotherapy? Secondary analysis of a randomized trial
Psychotherapies for depression are similarly effective, but the processes through which these therapies work have not been identified. We focus on psychological process changes during therapy as pr...
- Open Access
- 1 March 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (6) , 531-539
Interrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness
- 1 March 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (6) , 531-539
Open AccessInterrogating Associations Between Polygenic Liabilities and Electroconvulsive Therapy Effectiveness
- Open Access
- 14 February 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (6) , A3-A4
Table of Contents
- 14 February 2022
- Published by Elsevier in Biological Psychiatry
- Vol. 91 (6) , A3-A4
Open AccessTable of Contents
- 1 January 2022
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 90 (1) , 5-17
Individual differences in response to once versus twice weekly sessions of CBT and IPT for depression.
The Personalized Advantage Index (PAI) is a method to guide treatment selection by investigating which of two or more treatments is optimal for a given individual. Recently, it was shown that, on average, twice-weekly sessions of psychotherapy for depression lead to better outcomes compared to once-weekly sessions. The present study applied the PAI method to assess if subgroups of patients may have a differential response to psychotherapy frequency. Data came from a clinical trial (n = 200) randomizing depressed patients into different session frequencies: weekly sessions versus twice-weekly sessions. Machine-learning techniques were used to select pretreatment variables and develop a multivariable prediction model that calculated each patient's PAI. Differences in observed depression post-treatment scores (Beck Depression Inventory-II [BDI-II]) were tested between patients that received their PAI-indicated versus non-indicated session frequency. Between-group effect sizes (Cohen's d) were reported. We identified prognostic indicators generally associated with lower post-treatment BDI-II regardless of treatment assignment. In addition, we identified specific demographic and psychometric features associated with differential response to weekly- versus twice-weekly therapy sessions. Observed post-treatment BDI-II scores were significantly different between individuals receiving the PAI-indicated versus non-indicated session frequency (d = .37). Although a higher session frequency is more effective on average, different session frequencies seem beneficial for different patients. Future studies should externally validate these findings before they can be generalized to other settings. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
- 1 January 2022
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 90 (1) , 5-17
Individual differences in response to once versus twice weekly sessions of CBT and IPT for depression.
The Personalized Advantage Index (PAI) is a method to guide treatment selection by investigating which of two or more treatments is optimal for a given individual. Recently, it was shown that, on average, twice-weekly sessions of psychotherapy for depression lead to better outcomes compared to once-weekly sessions. The present study applied the PAI method to assess if subgroups of patients may have a differential response to psychotherapy frequency. Data came from a clinical trial (n = 200) randomizing depressed patients into different session frequencies: weekly sessions versus twice-weekly sessions. Machine-learning techniques were used to select pretreatment variables and develop a multivariable prediction model that calculated each patient's PAI. Differences in observed depression post-treatment scores (Beck Depression Inventory-II [BDI-II]) were tested between patients that received their PAI-indicated versus non-indicated session frequency. Between-group effect sizes (Cohen's d) were reported. We identified prognostic indicators generally associated with lower post-treatment BDI-II regardless of treatment assignment. In addition, we identified specific demographic and psychometric features associated with differential response to weekly- versus twice-weekly therapy sessions. Observed post-treatment BDI-II scores were significantly different between individuals receiving the PAI-indicated versus non-indicated session frequency (d = .37). Although a higher session frequency is more effective on average, different session frequencies seem beneficial for different patients. Future studies should externally validate these findings before they can be generalized to other settings. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
- 1 December 2021
- Published by American Psychiatric Association Publishing in American Journal of Psychotherapy
- Vol. 74 (4) , 150-156
Impact of Comorbid Personality Disorders on Depression Treatment in Routine Outpatient Care
Objective: The impact of personality disorder on treatment effectiveness for depression has been debated, and study results have been inconsistent. However, studies that report a negative impact of personality disorders on depression treatment outcomes are often characterized by uncontrolled treatment designs. Within such contexts, individuals with depression and personality disorders are at risk to receive suboptimal treatment. The aim of this retrospective observational study was to investigate whether and to what extent comorbid personality disorders were associated with the type and amount of depression treatment received in routine outpatient care. Methods: Retrospectively extracted data from electronic records of 1,455 outpatients treated for depression at several sites of a nationwide mental health provider in the Netherlands were included. The type and number of treatment sessions and visits were analyzed by using regression models. Results: Individuals with depression and comorbid personality disorders received more psychotherapy sessions than individuals without personality disorders, irrespective of depression severity. The number of pharmacotherapy sessions and supportive and crisis visits did not differ between individuals with and without comorbid personality disorders. Conclusions: Individuals with depression and personality disorders received more intensive treatment than individuals without comorbid personality disorders. These results conflict with treatment guidelines and recommendations from high-quality studies and may be indicative of overtreatment among this large group of patients.
- 1 December 2021
- Published by American Psychiatric Association Publishing in American Journal of Psychotherapy
- Vol. 74 (4) , 150-156
Impact of Comorbid Personality Disorders on Depression Treatment in Routine Outpatient Care
Objective: The impact of personality disorder on treatment effectiveness for depression has been debated, and study results have been inconsistent. However, studies that report a negative impact of personality disorders on depression treatment outcomes are often characterized by uncontrolled treatment designs. Within such contexts, individuals with depression and personality disorders are at risk to receive suboptimal treatment. The aim of this retrospective observational study was to investigate whether and to what extent comorbid personality disorders were associated with the type and amount of depression treatment received in routine outpatient care. Methods: Retrospectively extracted data from electronic records of 1,455 outpatients treated for depression at several sites of a nationwide mental health provider in the Netherlands were included. The type and number of treatment sessions and visits were analyzed by using regression models. Results: Individuals with depression and comorbid personality disorders received more psychotherapy sessions than individuals without personality disorders, irrespective of depression severity. The number of pharmacotherapy sessions and supportive and crisis visits did not differ between individuals with and without comorbid personality disorders. Conclusions: Individuals with depression and personality disorders received more intensive treatment than individuals without comorbid personality disorders. These results conflict with treatment guidelines and recommendations from high-quality studies and may be indicative of overtreatment among this large group of patients.
- Open Access
- 23 March 2021
- Published by Wiley in Depression and Anxiety
- Vol. 38 (9) , 940-949
Cognitive therapy and interpersonal psychotherapy reduce suicidal ideation independent from their effect on depression
Background Clinical guidelines suggest that psychological interventions specifically aimed at reducing suicidality may be beneficial. We examined the impact of two depression treatments, cognitive therapy (CT) and interpersonal psychotherapy (IPT) on suicidal ideation (SI) and explored the temporal associations between depression and SI over the course of therapy. Methods Ninety‐one adult (18–65) depressed outpatients from a large randomized controlled trial who were treated with CT (n = 37) and IPT (n = 54) and scored at least ≥1 on the Beck Depression Inventory II (BDI‐II) suicide item were included. Linear (two‐level) mixed effects models were used to evaluate the impact of depression treatments on SI. Mixed‐effects time‐lagged models were applied to examine temporal relations between the change in depressive symptoms and the change in SI. Results SI decreased significantly during treatment and there were no differential effects between the two intervention groups (B = −0.007, p = .35). Depressive symptoms at the previous session did not predict higher levels of SI at the current session (B = 0.016, p = .16). However, SI measured at the previous session significantly predicted depressive symptoms at the current session (B = 2.06, p < .001). Conclusions Both depression treatments seemed to have a direct association with SI. The temporal association between SI and depression was unidirectional with SI predicting future depressive symptoms during treatment. Our findings suggest that it may be most beneficial to treat SI first.
- 23 March 2021
- Published by Wiley in Depression and Anxiety
- Vol. 38 (9) , 940-949
Open AccessCognitive therapy and interpersonal psychotherapy reduce suicidal ideation independent from their effect on depression
Background Clinical guidelines suggest that psychological interventions specifically aimed at reducing suicidality may be beneficial. We examined the impact of two depression treatments, cognitive therapy (CT) and interpersonal psychotherapy (IPT) on suicidal ideation (SI) and explored the temporal associations between depression and SI over the course of therapy. Methods Ninety‐one adult (18–65) depressed outpatients from a large randomized controlled trial who were treated with CT (n = 37) and IPT (n = 54) and scored at least ≥1 on the Beck Depression Inventory II (BDI‐II) suicide item were included. Linear (two‐level) mixed effects models were used to evaluate the impact of depression treatments on SI. Mixed‐effects time‐lagged models were applied to examine temporal relations between the change in depressive symptoms and the change in SI. Results SI decreased significantly during treatment and there were no differential effects between the two intervention groups (B = −0.007, p = .35). Depressive symptoms at the previous session did not predict higher levels of SI at the current session (B = 0.016, p = .16). However, SI measured at the previous session significantly predicted depressive symptoms at the current session (B = 2.06, p < .001). Conclusions Both depression treatments seemed to have a direct association with SI. The temporal association between SI and depression was unidirectional with SI predicting future depressive symptoms during treatment. Our findings suggest that it may be most beneficial to treat SI first.
- 1 March 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 282, 1125-1131
Exploring differences in quality of life in clinical populations of depressed outpatients with and without personality disorders
- 1 March 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 282, 1125-1131
Exploring differences in quality of life in clinical populations of depressed outpatients with and without personality disorders
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 279, 149-157
Selecting the optimal treatment for a depressed individual: Clinical judgment or statistical prediction?
- 1 January 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 279, 149-157
Open AccessSelecting the optimal treatment for a depressed individual: Clinical judgment or statistical prediction?